Description |
Cajanin is a potent and orally active anti-melanogenic agent. Cajanin shows antiproliferative activity in MNT1 Cells. Cajanin efficiently decreases the melanin content. Cajanin down-regulates the mRNA and protein expression levels of MITF, tyrosinase, TRP-1 and Dct (TRP-2). Cajanin induces cell cycle arrest at G2/M and S phase. Cajanin stimulates osteoblast proliferation. Cajanin has the potential for the research of human hyperpigmented disorders and menopausal osteoporosis[1][2].
|
In Vitro |
Cajanin shows strong mitogenic as well as differentiation-promoting effects on osteoblasts[2]. Cajanin induces the phosphorylation of both Erk1/2 and Akt[2].
|
In Vivo |
Cajanin (10 mg/kg, p.o.; daily for 30 consecutive days) increases the BMD levels in all anatomical regions of the skeleton studied in Sprague Dawley rats[1].
|
Density | 1.5±0.1 g/cm3 |
Boiling Point | 605.5±55.0 °C at 760 mmHg |
Flash Point | 231.7±25.0 °C |
Exact Mass | 300.063385 |
PSA | 100.13000 |
LogP | 3.57 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |